104 related articles for article (PubMed ID: 38948099)
1. Safety and efficiency of Wharton's Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study.
Kabatas S; Civelek E; Boyalı O; Sezen GB; Ozdemir O; Bahar-Ozdemir Y; Kaplan N; Savrunlu EC; Karaöz E
World J Stem Cells; 2024 Jun; 16(6):641-655. PubMed ID: 38948099
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study.
Kabatas S; Civelek E; Savrunlu EC; Kaplan N; Boyalı O; Diren F; Can H; Genç A; Akkoç T; Karaöz E
World J Stem Cells; 2021 May; 13(5):470-484. PubMed ID: 34136076
[TBL] [Abstract][Full Text] [Related]
3. Functional Recovery After Wharton's Jelly-Derived Mesenchymal Stem Cell Administration in a Patient with Traumatic Brain Injury: A Pilot Study.
Kabatas S; Civelek E; Sezen GB; Kaplan N; Savrunlu EC; Cetin E; Diren F; Karaoz E
Turk Neurosurg; 2020; 30(6):914-922. PubMed ID: 33216342
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
Albu S; Kumru H; Coll R; Vives J; Vallés M; Benito-Penalva J; Rodríguez L; Codinach M; Hernández J; Navarro X; Vidal J
Cytotherapy; 2021 Feb; 23(2):146-156. PubMed ID: 32981857
[TBL] [Abstract][Full Text] [Related]
5. Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy.
Kabataş S; Civelek E; Kaplan N; Savrunlu EC; Sezen GB; Chasan M; Can H; Genç A; Akyuva Y; Boyalı O; Diren F; Karaoz E
World J Exp Med; 2021 Mar; 11(2):17-29. PubMed ID: 33821203
[TBL] [Abstract][Full Text] [Related]
6. Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.
Özmert E; Arslan U
Stem Cell Res Ther; 2020 Jan; 11(1):25. PubMed ID: 31931872
[TBL] [Abstract][Full Text] [Related]
7. Wharton's jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial.
Ashoobi MT; Hemmati H; Aghayan HR; Zarei-Behjani Z; Keshavarz S; Babaloo H; Maroufizadeh S; Yousefi S; Farzin M; Vojoudi E
Cell Tissue Res; 2024 Feb; 395(2):211-220. PubMed ID: 38112806
[TBL] [Abstract][Full Text] [Related]
8. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
[TBL] [Abstract][Full Text] [Related]
9. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
[TBL] [Abstract][Full Text] [Related]
10. A Retrospective Analysis of Safety and Efficacy of Wharton's Jelly Stem Cell Administration in Children with Spina Bifida.
Boruczkowski D; Zdolińska-Malinowska I
Stem Cell Rev Rep; 2019 Oct; 15(5):717-729. PubMed ID: 31222411
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy.
Boyalı O; Kabatas S; Civelek E; Ozdemir O; Bahar-Ozdemir Y; Kaplan N; Savrunlu EC; Karaöz E
World J Clin Cases; 2024 Mar; 12(9):1585-1596. PubMed ID: 38576742
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells Derived from Wharton's Jelly Can Differentiate into Schwann Cell-Like Cells and Promote Peripheral Nerve Regeneration in Acellular Nerve Grafts.
Choi SJ; Park SY; Shin YH; Heo SH; Kim KH; Lee HI; Kim JK
Tissue Eng Regen Med; 2021 Jun; 18(3):467-478. PubMed ID: 33515168
[TBL] [Abstract][Full Text] [Related]
14. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
[TBL] [Abstract][Full Text] [Related]
15. Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.
Chan AML; Ng AMH; Yunus MHM; Idrus RH; Law JX; Yazid MD; Chin KY; Yusof MRM; Ng SN; Koh B; Lokanathan Y
Stem Cell Res Ther; 2024 Jun; 15(1):160. PubMed ID: 38835014
[TBL] [Abstract][Full Text] [Related]
16. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton's Jelly-Derived Mesenchymal Stem Cells into the Brain.
Kim H; Na DL; Lee NK; Kim AR; Lee S; Jang H
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070050
[TBL] [Abstract][Full Text] [Related]
18. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury.
Wang S; Cheng H; Dai G; Wang X; Hua R; Liu X; Wang P; Chen G; Yue W; An Y
Brain Res; 2013 Sep; 1532():76-84. PubMed ID: 23942181
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Liau LL; Ruszymah BHI; Ng MH; Law JX
Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
[TBL] [Abstract][Full Text] [Related]
20. All but Small: miRNAs from Wharton's Jelly-Mesenchymal Stromal Cell Small Extracellular Vesicles Rescue Premature White Matter Injury after Intranasal Administration.
Tscherrig V; Steinfort M; Haesler V; Surbek D; Schoeberlein A; Joerger-Messerli MS
Cells; 2024 Mar; 13(6):. PubMed ID: 38534387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
